Malin Attracts Sovereign Wealth Funds, Backs Bill Gates Venture

Dun Laoghaire-based Malin Corporation, an Ireland life sciences investor company, has raised €330 million from key institutional and high net worth investors. Malin is targeted to be one of Europe’s largest biotech initial public offerings. Malin plans to provide long-term capital to life science and medical device companies backed by industry experts. The investment stakes in the young life science ventures will range from a low of 8% to 85%.

Kymab

[ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]


Contact the writer or creator of this article or page.
Questions or comments: support(at)swfinstitute(dot)org
Follow on Twitter at @swfinstitute and @sovereignfunds
Learn, Attend and Network: Institutional Investor Events and Summits
Go Back: HOME: Sovereign Wealth Fund Institute
 
institutional investor investment mandates